Search research articles
Contact Us
Filters
Showing results (41-50 of 43) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 43 results.
The Journal of Reproductive Medicine
|
March 1, 1993
Evaluation of low-dose estrogen and progestin therapy in postmenopausal women. A double-blind, prospective study of sequential versus continuous therapy
A A Luciano, M J De Souza, M P Roy, et al.
F&S Reports
|
July 5, 2021
In vitro fertilization outcomes after preimplantation genetic testing for chromosomal structural rearrangements comparing fluorescence in-situ hybridization, microarray comparative genomic hybridization, and next-generation sequencing
Chantal B Bartels, Reeva Makhijani, Prachi Godiwala, et al.
Journal of Ovarian Research
|
January 28, 2019
Low dose human chorionic gonadotropin administration at the time of gonadotropin releasing-hormone agonist trigger versus 35 h later in women at high risk of developing ovarian hyperstimulation syndrome - a prospective randomized double-blind clinical trial
L L Engmann, B S Maslow, L A Kaye, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 43) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 43 results.
The Journal of Reproductive Medicine
|
March 1, 1993
Evaluation of low-dose estrogen and progestin therapy in postmenopausal women. A double-blind, prospective study of sequential versus continuous therapy
A A Luciano, M J De Souza, M P Roy, et al.
F&S Reports
|
July 5, 2021
In vitro fertilization outcomes after preimplantation genetic testing for chromosomal structural rearrangements comparing fluorescence in-situ hybridization, microarray comparative genomic hybridization, and next-generation sequencing
Chantal B Bartels, Reeva Makhijani, Prachi Godiwala, et al.
Journal of Ovarian Research
|
January 28, 2019
Low dose human chorionic gonadotropin administration at the time of gonadotropin releasing-hormone agonist trigger versus 35 h later in women at high risk of developing ovarian hyperstimulation syndrome - a prospective randomized double-blind clinical trial
L L Engmann, B S Maslow, L A Kaye, et al.
Page
of 5